Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
ConclusionsOverall, this study demonstrates that modulation of the immunosuppressive TIME is required to unlock the benefits of ICIs and radiotherapy to induce immunologic rejection of treatment-refractory established solid tumors.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Genital Warts | Head and Neck Cancer | Human Papillomavirus (HPV) | Immunotherapy | Melanoma | Skin Cancer | Study